Pfizer has expanded its COVID-19 vaccine trial to include teens. Some say it's risky. Others argue it's necessary.
After months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16.
Pfizer has expanded its COVID-19 vaccine trial to include teens. Some say it's risky. Others argue it's necessary.
USATODAY.com
0 shares
1 views